Getting paid for
Precision Cardiac Amyloid
Reimbursable today via CPT 0932T on outpatient studies, with a dedicated Medicare inpatient add-on effective October 1, 2026.
Two settings. Two codes.
Most echocardiograms are performed in the outpatient setting, and most reimbursement conversations stop there. InVision Precision Cardiac Amyloid is paid on both sides of the house.
Outpatient and office. CPT 0932T covers the augmentative analysis of an echocardiogram demonstrating preserved ejection fraction. In the hospital outpatient setting it is separately payable, paid in addition to the echocardiogram, not bundled into it, the same way strain and 3D imaging are billed alongside the study.
Inpatient. InVision PCA has its own Medicare New Technology Add-on Payment, code XEZZXLC, up to $2,275 per eligible Medicare stay, on top of the MS-DRG, effective October 1, 2026.
Medicare fee-for-service. Medicare Advantage and commercial inpatient payment follow your contracts with those plans.
| Setting | Report | Rate | Status |
|---|---|---|---|
| Hospital outpatientTechnical component | CPT 0932TAPC 5743 | $313 | Payable now |
| Physician professionalAny place of service | CPT 0932T-26Modifier 26 | — | Payable now |
| OfficeAny place of service | CPT 0932TGlobal | — | Payable now |
| Hospital inpatientNew Technology Add-on Payment | XEZZXLCICD-10-PCS | Up to $2,275Per eligible Medicare stay | Effective 10/01/2026 |
Request Reimbursement Support
Need help with implementation, coding, or payer conversations? Send your request and our team will follow up.
You can also email us directly at reimbursement@invisionmedtech.com.